| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.14 | 0.004 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.15 | 0.005 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.16 | 0.005 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.005 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.096 | 0.006 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.097 | 0.006 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.098 | 0.007 |